by The global Mosquito Borne Disease Market is estimated to be valued at US$ 3.11 Bn or Mn in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Mosquito borne diseases like malaria, dengue, chikungunya, zika virus etc which transmitted through the bite of infected female mosquitoes. Mosquito borne disease treatments aims to minimize symptoms, prevent complications, and reduce transmission risks. Drugs likes antimalarial, antiviral etc are used for treatment of specific mosquito borne diseases.
Market key trends:
One of the key trend in the market is development of novel drugs and vaccines. Development of novel drugs and vaccines for treatment and prevention of mosquito borne diseases is one of the key focus areas of market players and research institutes. For instance, researchers are working on development of dengue and zika virus vaccines. Similarly, new antimalarial drugs are being developed to overcome resistance issues. Novel drug development is expected to drive the market growth during the forecast period.
Market Key Trends:
The mosquito borne disease market is witnessing high growth due to increasing prevalence of vector-borne diseases globally. Rapid urbanization and rising global temperatures have expanded the geographical reach of mosquitoes, resulting in the transmission of diseases like dengue, malaria, chikungunya, Zika virus etc to new locations. Lack of effective prevention measures in many developing and underdeveloped regions further boosts the risk of these illnesses.
SWOT Analysis:
Strength: Growing infection rates combined with rising investment in research and development of novel treatments and vaccines.
Weakness: Limited healthcare access and infrastructure in endemic areas hampers control efforts.
Opportunity: Increasing awareness about vector control measures creates potential for profitable intervention programs.
Threats: Emergence of drug and insecticide resistance challenges long term solution approaches.
Key Takeaways:
The Global Mosquito Borne Disease Market Size is expected to witness high growth, exhibiting CAGR of 7.3% over the forecast period, due to increasing prevalence of vector-borne diseases worldwide. The market size for 2023 is estimated to be US$ 3.11 Bn.
Regional analysis: Asia Pacific retains the largest market share led by high endemicity in populous developing nations like India and Indonesia. Growing urbanization and infrastructure projects in the region have boosted mosquito habitats.
Key players operating in the Mosquito Borne Disease market are GlaxoSmithKline plc, Sanofi S.A., Pfizer Inc., Merck & Co. Inc., Novartis AG, Johnson & Johnson, Eisai Co. Ltd, Takeda Pharmaceuticals, AstraZeneca, Valeant Pharmaceuticals, Mitsubishi Tanabe Pharma, Abbott, F. Hoffmann-La Roche Ltd, Sun Pharmaceutical Industries Ltd, Lupin Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Serum Institute of India Pvt. Ltd., CSL Limited, Teva Pharmaceutical Industries Ltd.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
